The company have demonstrably boosted the course of the new treatment for ATTR-CM, utilizing Attruby. Initial patient results suggests promising outcomes for patients suffering from this severe condition. This effort https://attrcm054523.techionblog.com/42376987/bridgebio-progresses-cardiac-amyloidosis-treatment-using-the-drug